Table 1.
Demographic and primary cancer characteristics overall and by life status among five-year survivors of childhood cancer
| Total | Alive | Dead | |
|---|---|---|---|
| All Survivors* | 34033 | 30075 (88.4%) | 3958 (11.6%) |
| Sex | |||
| Male | 18983 | 16628 (87.6%) | 2355 (12.4%) |
| Female | 15050 | 13447 (89.3%) | 1603 (10.7%) |
| Race/Ethnicity | |||
| Non-Hispanic white | 21781 | 19575 (89.9%) | 2206 (10.1%) |
| Non-Hispanic black | 2022 | 1817 (89.9%) | 205 (10.1%) |
| Hispanic | 2287 | 2094 (91.6%) | 193 (8.4%) |
| Others | 2057 | 1849 (89.8%) | 208 (10.2%) |
| Unknown | 5886 | 4740 (80.5%) | 1146 (19.5%) |
| Treatment Era | |||
| 1970-1979 | 9416 | 7548 (80.2%) | 1868 (19.8%) |
| 1980-1989 | 13181 | 11699 (88.8%) | 1482 (11.2%) |
| 1990-1999 | 11436 | 10828 (94.7%) | 608 (5.3%) |
| Age at Diagnosis (years) | |||
| 0-4 | 13463 | 12319 (91.5%) | 1144 (8.5%) |
| 5-9 | 7826 | 6950 (88.8%) | 876 (11.2%) |
| 10-14 | 7144 | 6185 (86.6%) | 959 (13.4%) |
| 15-20 | 5600 | 4621 (82.5%) | 979 (17.5%) |
| Survival after Diagnosis (years) | |||
| 5-9 | 4210 | 2349 (55.8%) | 1861 (44.2%) |
| 10-14 | 6298 | 5523 (87.7%) | 775 (12.3%) |
| 15-19 | 5285 | 4758 (90.0%) | 527 (10.0%) |
| 20-24 | 6721 | 6343 (94.4%) | 378 (5.6%) |
| 25-29 | 5964 | 5692 (95.4%) | 272 (4.6%) |
| 30-34 | 4051 | 3924 (96.9%) | 127 (3.1%) |
| ≥35 | 1504 | 1486 (98.8%) | 18 (1.2%) |
| Diagnosis | |||
| Leukemia | 10199 | 9019 (88.4%) | 1180 (11.6%) |
| Acute lymphoblastic leukemia | 8500 | 7557 (88.9%) | 943 (11.1%) |
| Acute myeloid leukemia | 1222 | 1101 (90.1%) | 121 (9.9%) |
| Other leukemia | 477 | 361 (75.7%) | 116 (24.3%) |
| Hodgkin lymphoma | 4332 | 3647 (84.2%) | 685 (15.8%) |
| Non-Hodgkin lymphoma | 2837 | 2621 (92.4%) | 216 (7.6%) |
| CNS tumors | 6369 | 5443 (85.5%) | 926 (14.5%) |
| Astrocytoma | 3904 | 3383(86.7%) | 521 (13.3%) |
| Medulloblastoma, PNET | 1380 | 1133 (82.1%) | 247 (17.9%) |
| Other CNS | 1085 | 927 (85.4%) | 158 (14.6%) |
| Wilms tumor | 3055 | 2898 (94.9%) | 157 (5.1%) |
| Neuroblastoma | 2632 | 2457 (93.4%) | 175 (6.6%) |
| Rhabdomyosarcoma | 1679 | 1510 (89.9%) | 169 (10.1%) |
| Bone tumors | 2930 | 2480 (84.6%) | 450 (15.4%) |
| Ewing sarcoma | 997 | 813 (81.5%) | 184 (18.5%) |
| Osteosarcoma | 1771 | 1518 (85.7%) | 253 (14.3%) |
| Other bone tumors | 162 | 149 (92.0%) | 13 (8.0%) |